Jama Network

JAMA Neurology : Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Informações:

Sinopsis

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD. Related Content: Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder